Applied Genetic Technologies Corporation (AGTC)

Etorro trading 970x250
Applied Genetic Technologies Corporation (AGTC) Logo

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company’s advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which has completed Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate for the patients with advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and three preclinical programs in targeting central nervous system disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, and adrenoleukodystrophy. It has collaboration agreements with Synpromics Limited; University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida. Address: 14193 NW 119th Terrace, Alachua, FL, United States, 32615

Applied Genetic Technologies Corporation News and around…

Latest news about Applied Genetic Technologies Corporation (AGTC) common stock and company :

AGTC Announces Two Key Leadership Team Appointments
14 Oct, 2021 Yahoo! Finance

- AGTC Welcomes Susan Schneider as the Chief Medical Officer and Sarah C. DiSalvatore as the Vice President of Clinical Operations -GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases (IRDs), today announced the appointment of Susan Schneider, M.D., as Chief

AGTC to Present at Upcoming Cell & Gene Meeting on the Mesa
12 Oct, 2021 Yahoo! Finance

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases (IRDs), today announced Sue Washer, President and Chief Executive Officer of AGTC, will present at the 2021 Cell & Gene Meeting on the Mesa being held October 12-14, 2021. Ms. Washer will provide a corporat

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

AGTC to Present at Upcoming Cell & Gene Management Meeting on the Mesa
12 Oct, 2021 Yahoo! Finance

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases (IRDs), today announced Sue Washer, President and Chief Executive Officer of AGTC, will present at the 2021 Cell & Gene Management Meeting on the Mesa being held October 12-14, 2021. Ms. Washer will provide

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
30 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
29 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

AGTC Clinical Trial Investigators to Present Data from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Fourteenth International Symposium on Retinal Degeneration
28 Sep, 2021 FinancialContent

Dr. Rachel Huckfeldt and Dr. Paul Yang to Present 12-Month Findings and Analysis from AGTC’s Clinical Trials

AGTC to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
27 Sep, 2021 FinancialContent
Applied Genetic: Q4 Earnings Insights
27 Sep, 2021 FinancialContent

Applied Genetic(NASDAQ:AGTC) stock fell by 5.56% on Friday after the company reported its Q4 earnings results on Thursday, ...

Kids Suffer Adverse Reactions In Applied Genetic's Color Blindness Gene Therapy Trial
24 Sep, 2021 FinancialContent

After escalating the dose in its pediatric gene therapy trial,Applied Genetic Technologies Corporation(NASDAQ: AGTC) has ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
24 Sep, 2021 FinancialContent

Gainers Cellect Biotechnology (NASDAQ:APOP) stock moved upwards by 251.16% to $21.07 during Friday's pre-market ...

AGTC Provides Financial Results for the Fourth Quarter and Year Ended June 30, 2021
23 Sep, 2021 FinancialContent
Earnings Scheduled For September 23, 2021
23 Sep, 2021 FinancialContent

Companies Reporting Before The Bell • Rite Aid (NYSE:RAD) is projected to report quarterly loss at $0.42 per share on ...

The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
19 Sep, 2021 FinancialContent

Biotech stocks declined for the week endingSept. 17, extending the losses from the previous week. European Society for Medical ...

AGTC to Host Fourth Quarter and 2021 Fiscal Year End Financial Results Conference Call and Webcast on September 23, 2021
16 Sep, 2021 FinancialContent
AGTC to Participate in Clinical Trials in Rare Diseases Conference Panel and Case Study
09 Sep, 2021 FinancialContent

AGTC patient advocacy executive director and director of patient enrollment to speak at Clinical Trials in Rare Diseases Conference

AGTC is Excited to Announce Seasoned Healthcare Financial and Operations Executive Jonathan I. Lieber as their new Chief Financial Officer
08 Sep, 2021 FinancialContent
AGTC to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep, 2021 FinancialContent
AGTC to Present at the 2021 Wells Fargo Virtual Healthcare Conference
02 Sep, 2021 FinancialContent
Greater Gift, AGTC, and 2020 On-site Partner To Honor & Celebrate Clinical Trial Participants and Provide Eye Exams to Underserved Children in the Local Community
24 Aug, 2021 FinancialContent
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
20 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

AGTC Announces Sponsorship of Achroma Corp’s No Roadblocks Program
19 Aug, 2021 FinancialContent
Could The Applied Genetic Technologies Corporation (NASDAQ:AGTC) Ownership Structure Tell Us Something Useful?
19 Aug, 2021 Yahoo! Finance

If you want to know who really controls Applied Genetic Technologies Corporation ( NASDAQ:AGTC ), then you'll have to...

AGTC Appoints Ophthalmology and Retinal Disease Specialist and Industry R&D Veteran Yehia Hashad, MD to its Board of Directors
18 Aug, 2021 FinancialContent
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
18 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
17 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Applied Genetic Technologies Corporation (AGTC) is a NASDAQ Common Stock listed in , ,

970x250